Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Elite Ivy Investment LLC is a hedge fund management firm headquartered in Millburn, New Jersey. Founded in 2016 and led by Yingchao Zhang, the firm manages the Elite Ivy Investment LLC fund, which focuses on a diverse range of financial instruments including equities, options, futures, debt securities, and commodities. The company is primarily recognized in the healthcare sector through its strategic relationship with Zhongchao Inc. (NASDAQ: ZCMD), a leading provider of healthcare information and education services in China, which maintains a minority investment stake in the fund. Elite Ivy Investment operates as a pooled investment vehicle, providing capital management and investment advisory services. While not a direct drug developer, its activities are closely integrated with the financial and educational aspects of the healthcare industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Elite Ivy Investment.